The 5th Consortium Meeting of IBDase, hosted by partner UNICF1, was planned be held in Clermont-Ferrand (France) on April 21, 2010. However, due to the difficult airtraffic situation, the meeting had to be cancelled and currently, a new date is searched.

Partner UNICF1 (lead by Arlette Darfeuille-Michaud) has recently published 3 papers on adherent-invasive E.coli and IBD:
- F.A. Carvalho, N. Barnich, A. Sivignon, C. Darcha, C.H.F. Chan, C.P. Stanners and A. Darfeuille-Michaud (2009) Crohn's disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM. The Journal of Experimental Medicine 206 (10): 2179-2189.
- P. Lapaquette, A.-L.Glasser, A. Huett, R. J. Xavier and A. Darfeuille-Michaud (2010) Crohn's disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly. Cellular Microbiology 12 (1): 99-113.
- S. Miquel, L. Claret, R. Bonnet, I. Dorboz, N. Barnich and A. Darfeuille-Michaud (in press) Role of decreased levels of Fis histone-like protein in Crohn's disease-associated AIEC LF82 bacteria interacting with intestinal epithelial cells. Journal of Bacteriology. e-publication ahead of print

The 4th Consortium Meeting of IBDase was held in Bilbao on October 20-21, 2009. The meeting was hosted by PROGENIKA. The work packages progress and future objectives were discussed during the meeting sessions.

The University Hospital Bern (Inselspital) has released a communication to the press on its contribution to groundbreaking research results on the role of Meprin in IBD - work performed mainly before the onset of IBDase and published in the journal Mucosal Immunology (see 'Publication' section). download press release (in german)

The 3rd Consortium meeting of IBDase was held in Rome on April 16, 2009. The meeting was hosted by Giovanni Monteleone and Monica Boirivant from the University of Rome "Tor Vergata" and the Istituto Superiore di Sanità. The work packages progress and future objectives were discussed during the meeting sessions.

The 2nd Consortium Meeting of IBDase was held in Milan, October 7-8, 2008 at the European Institute of Oncology (Campus IFOM-IEO). The meeting will precede the European Mucosal Immunology Group meeting, EMIG2008, organised by Maria Rescigno (IBDase partner, IEO).

The Kick-off meeting was hosted by the project coordinator (UBERN). All partners and stakeholders were represented. The project officer, from the European Commission, was also present. During these two days, the main responsibilities, rules for partnership and scientific project objectives were discussed.